Keller Salka, Wilson John T, Patilea Gabriela I, Kern Hanna B, Convertine Anthony J, Stayton Patrick S
Department of Bioengineering, University of Washington, Box 355061, Seattle, WA 98195-1721, USA.
J Control Release. 2014 Oct 10;191:24-33. doi: 10.1016/j.jconrel.2014.03.041. Epub 2014 Mar 31.
Synthetic subunit vaccines need to induce CD8(+) cytotoxic T cell (CTL) responses for effective vaccination against intracellular pathogens. Most subunit vaccines primarily generate humoral immune responses, with a weaker than desired CD8(+) cytotoxic T cell response. Here, a neutral, pH-responsive polymer micelle carrier that alters intracellular antigen trafficking was shown to enhance CD8(+) T cell responses with a correlated increase in cytosolic delivery and a decrease in exocytosis. Polymer diblock carriers consisted of a N-(2-hydroxypropyl) methacrylamide corona block with pendent pyridyl disulfide groups for reversible conjugation of thiolated ovalbumin, and a tercopolymer ampholytic core-forming block composed of propylacrylic acid (PAA), dimethylaminoethyl methacrylate (DMAEMA), and butyl methacrylate (BMA). The diblock copolymers self-assembled into 25-30nm diameter micellar nanoparticles. Conjugation of ovalbumin to the micelles significantly enhanced antigen cross-presentation in vitro relative to free ovalbumin, an unconjugated physical mixture of ovalbumin and polymer, and a non-pH-responsive micelle-ovalbumin control. Mechanistic studies in a murine dendritic cell line (DC 2.4) demonstrated micelle-mediated enhancements in intracellular antigen retention and cytosolic antigen accumulation. Approximately 90% of initially internalized ovalbumin-conjugated micelles were retained in cells after 1.5h, compared to only ~40% for controls. Furthermore, cells dosed with conjugates displayed 67-fold higher cytosolic antigen levels relative to soluble ovalbumin 4h post uptake. Subcutaneous immunization of mice with ovalbumin-polymer conjugates significantly enhanced antigen-specific CD8(+) T cell responses (0.4% IFN-γ(+) of CD8(+)) compared to immunization with soluble protein, ovalbumin and polymer mixture, and the control micelle without endosome-releasing activity. Additionally, pH-responsive carrier facilitated antigen delivery to antigen presenting cells in the draining lymph nodes. As early as 90min post injection, ova-micelle conjugates were associated with 28% and 55% of dendritic cells and macrophages, respectively. After 24h, conjugates preferentially associated with dendritic cells, affording 30-, 3-, and 3-fold enhancements in uptake relative to free protein, physical mixture, and the non-pH-responsive conjugate controls, respectively. These results demonstrate the potential of pH-responsive polymeric micelles for use in vaccine applications that rely on CD8(+) T cell activation.
合成亚单位疫苗需要诱导CD8(+)细胞毒性T细胞(CTL)反应,以有效预防针对细胞内病原体的疫苗接种。大多数亚单位疫苗主要产生体液免疫反应,其CD8(+)细胞毒性T细胞反应比预期的要弱。在这里,一种改变细胞内抗原运输的中性、pH响应性聚合物胶束载体被证明可以增强CD8(+) T细胞反应,同时伴随着胞质递送的相关增加和胞吐作用的减少。聚合物双嵌段载体由带有吡啶二硫基团的N-(2-羟丙基)甲基丙烯酰胺冠醚嵌段组成,用于硫醇化卵清蛋白的可逆偶联,以及由丙烯酸丙酯(PAA)、甲基丙烯酸二甲氨基乙酯(DMAEMA)和甲基丙烯酸丁酯(BMA)组成的三元共聚物两性离子核形成嵌段。双嵌段共聚物自组装成直径为25-30nm的胶束纳米颗粒。与游离卵清蛋白、卵清蛋白和聚合物的未偶联物理混合物以及非pH响应性胶束-卵清蛋白对照相比,卵清蛋白与胶束的偶联在体外显著增强了抗原交叉呈递。在小鼠树突状细胞系(DC 2.4)中的机制研究表明,胶束介导的细胞内抗原保留和胞质抗原积累增强。在1.5小时后,约90%最初内化的卵清蛋白偶联胶束保留在细胞中,而对照仅为约40%。此外,摄取后4小时,用偶联物处理的细胞相对于可溶性卵清蛋白的胞质抗原水平高67倍。与用可溶性蛋白、卵清蛋白和聚合物混合物以及没有内体释放活性的对照胶束免疫相比,用卵清蛋白-聚合物偶联物皮下免疫小鼠显著增强了抗原特异性CD8(+) T细胞反应(CD8(+)的0.4% IFN-γ(+))。此外,pH响应性载体促进了抗原递送至引流淋巴结中的抗原呈递细胞。早在注射后90分钟,卵清蛋白-胶束偶联物分别与28%和55%的树突状细胞和巨噬细胞相关联。24小时后,偶联物优先与树突状细胞相关联,相对于游离蛋白、物理混合物和非pH响应性偶联物对照,摄取分别提高了30倍、3倍和3倍。这些结果证明了pH响应性聚合物胶束在依赖CD8(+) T细胞活化的疫苗应用中的潜力。